Optimization of the molecular genetics for the diagnosis of early mycosis fungoides

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access


BACKGROUND: Mycosis fungoides (MF) is the most common disease among the cutaneous T-cell lymphomas (85–90%). The accuracy of the diagnosis of MF, which is confirmed only by clinical, histological and immunohistochemical signs, is 50–75%.

AIMS: To investigate genetic marker STAT4 for early diagnosis of mycosis fungoides.

MATERIALS AND METHODS: A study involving 42 patients with MF and chronic benign dermatoses (CBD) was performed. The analysis of gene expression STAT4 was carried out by TaqMan Real time-PCR. The objects of the study were lesional skin samples of patients. A group with MF consisted of 29 patients, a group with CBD consisted of 13 patients, a control group included 10 healthy volunteers.

RESULTS: The study revealed that the level of STAT4 gene expression showed a significant (9 times) increase in the expression of gene STAT4 in patients with MF (168.2) compared with patients with CBD (18.5; p <0.001) and 561 times — with healthy volunteers (0.3; p <0.001).

CONCLUSION: For early diagnosis of MF the level of expression STAT4 is of great importance. Inclusion of STAT4 in the list of diagnostic algorithm increases the accuracy of differential diagnosis of MF and CBD from 59.1 to 92.2%.

Full Text

Restricted Access

About the authors

Olga Yu. Olisova

I.M.Sechenov First Moscow State Medical University (Sechenov University)

Email: olisovaolga@mail.ru
ORCID iD: 0000-0003-2482-1754
SPIN-code: 2500-7989

Dr. Sci. (Med.), Professor

Russian Federation, 8-2, Trubetskaya street, Moscow, 119992

Ekaterina V. Grekova

I.M.Sechenov First Moscow State Medical University (Sechenov University)

Author for correspondence.
Email: grekova_kate@mail.ru
ORCID iD: 0000-0002-7968-9829
SPIN-code: 8028-5545

Assistant, Professor

Russian Federation, 8-2, Trubetskaya street, Moscow, 119992

Ekaterina A. Alekseeva

I.M.Sechenov First Moscow State Medical University (Sechenov University); Research Centre for Medical Genetics

Email: ekater.alekseeva@gmail.com

Cand. Sci. (Biol.), Senior Research Associate

Russian Federation, 8-2, Trubetskaya street, Moscow, 119992; Moscow

Dmitry V. Zaletaev

I.M.Sechenov First Moscow State Medical University (Sechenov University), Research Centre for Medical Genetics

Email: zalnem@mail.ru
ORCID iD: 0000-0002-9323-2673
SPIN-code: 9836-2326

Dr. Sci. (Biol.), Professor

Russian Federation, 8-2, Trubetskaya street, Moscow, 119992; Moscow


  1. Poddubnaya IV, Savchenko VG, eds. Russian clinical guidelines for the diagnosis and treatment of lymphoproliferative diseases. Moscow : MMA MediaMedika; 2014. 128 p. (In Russ).
  2. Rodd AL, Ververis K, Karagiannis TC. Current and emerging therapeutics for cutaneous T-cell lymphoma: histone deacetylase inhibitors. Lymphoma. 2012;2012:1–10. doi: 10.1155/2012/290685
  3. Alibert JL. Description des maladies de la peau. Barrois l’aine et Fils; 1806. (In French).
  4. Zaslavskiy DV, Sydikov AA, Zaytsev BC, et al. Detection of antigen of herpes simplex virus types 1,2, human papilloma and Epstein–Barr in patients with large-and small-plaque parapsoriasis. Problems in Medical Mycology. 2013;15(2):78. (In Russ).
  5. Bratseva EV, Rotanov CV. Current approaches to diagnostics of mycosis fungoides. Vestnik dermatologii i venerologii. 2010;(6):16–22. (In Russ).
  6. Olisova OYu, Vladimirova EV, Babushkin AM. The skin and the sun. Russian Journal of Skin and Venereal Diseases. 2012;15(6):57–62. (In Russ.)
  7. Johnson VE, Vonderheid EC, Hess AD, et al. Genetic markers associated with progression in early mycosis fungoides. J Eur Acad Dermatol Venereol. 2014;28(11):1431–1435. doi: 10.1111/jdv.12299
  8. Olsen EA, Whittaker S, Kim YH, et al. Clinical end points and response criteria in mycosis fungoides and Sezary syndrome: a consensus statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer. J Clin Oncol. 2011;29(18):2598–2607. doi: 10.1200/JCO.2010.32.0630
  9. Belousova IE. Federal clinical guidelines for the management of patients with skin lymphomas. Moscow; 2015. 37 p. (In Russ).
  10. Kungurov NV, Malishevskaya NP, Kokhan MM, et al. Malignant neoplasms of the skin: morbidity, diagnostic errors, organization of early detection, prevention. Kurgan : Zauralie; 2010. Р. 13–15. (In Russ).
  11. Bernier C, Nguyen JM, Quereux G, et al. CD13 and TCR clone: markers of early mycosis fungoides. Acta Dermatol Venereol. 2007;87(2):155–159. doi: 10.2340/00015555-0197
  12. Netchiporouk E, Litvinov IV, Moreau L, et al. Deregulation in STAT signaling is important for cutaneous T-cell lymphoma (CTCL) pathogenesis and cancer progression. Cell Cycle. 2014;13(21):3331–3335. doi: 10.4161/15384101.2014.965061
  13. Sommer VH, Clemmensen OJ, Nielsen O, et al. In vivo activation of STAT3 in cutaneous T-cell lymphoma. Evidence for an antiapoptotic function of STAT3. Leukemia. 2004;18(7):1288–1295. doi: 10.1038/sj.leu.2403385
  14. Litvinov I, Cordeiro B, Fredholm S, et al. Analysis of STAT4 expression in cutaneous T-cell lymphoma (CTCL) patients and patient-derived cell lines. Cell Cycle. 2014;13(18):2975–2982. doi: 10.4161/15384101.2014.947759
  15. Nishikomori R, Usui T, Wu CY, et al. Activated STAT4 has an essential role in Th1 differentiation and proliferation that is independent of its role in the maintenance of IL-12Rβ2 chain expression and signaling. J Immunol. 2002;169(8):4388–4398. doi: 10.4049/jimmunol.169.8.4388
  16. Paltsev MA, ed. Introduction to molecular diagnostics. Vol. 2. Moscow : Medicina; 2011. Р. 322–335. (In Russ).
  17. Yudin SV, Protasev VB, Podkopaev RYu, Yudin AS. Methodology of statistical acceptance control based on the Bayes approach (hypergeometric distribution). Modern High Technologies. 2018;(10):161–165. (In Russ).

Supplementary files

Supplementary Files
1. Fig. 1. Expression of the STAT4 gene in patients with fungal mycosis and chronic benign dermatoses compared with healthy donors.

Download (265KB)
2. Fig. 2. Diagnostic algorithm of early stages of fungal mycosis

Download (459KB)

Copyright (c) 2021 Eco-Vector

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: 015912 от 28.03.1997 г
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ЭЛ № ФС 77 - 80653 от 15.03.2021 г

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies